UK Govt Asks: Are Trial Sponsors Ready For No-Deal Brexit?
Executive Summary
Pharma firms are being asked to let the government know how prepared they are in terms of ensuring supplies of investigational medicines and other clinical trial supplies in the event of a no-deal Brexit at the end of October.
You may also be interested in...
Will Pharma Firms Bear Cost Of UK Govt’s Latest No-Deal Brexit Supply Plans?
Life science companies are uneasy over the government’s latest proposals for emergency medical supplies to the UK if the country leaves the EU without a deal.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.